MARC Record from marc_columbia

LEADER: 02311cam a2200433Mi 4500
001 6247756
005 20221122012223.0
008 070616t20072007gw a 100 0 eng d
016 7 $a983895600$2DE-101
020 $a9783540723097 (hd.bd.)
020 $a3540723099 (hd.bd.)
029 0 $aOHX$bhar070057324
029 1 $aNZ1$b11479923
029 1 $aAU@$b000042331377
029 1 $aGEBAY$b10417463
035 $a(OCoLC)137248701
035 $a(OCoLC)ocn137248701
035 $a(NNC)6247756
035 $a6247756
040 $aOHX$cOHX$dBTCTA$dBAKER$dYDXCP$dGSU$dAU@$dGEBAY
050 4 $aHF5387$b.B8726 2007
072 7 $aHF$2lcco
082 04 $a174.4$222
245 00 $aBusiness ethics of innovation /$cG. Hanekamp (ed.).
260 $aBerlin ;$aNew York :$bSpringer,$c[2007], ©2007.
300 $axiii, 110 pages :$billustrations ;$c24 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aEthics of science and technology assessment.,$x1860-4803 ;$vv. 31
500 $aInternational conference proceedings.
504 $aIncludes bibliographical references.
505 0 $aBusiness ethics of innovation : an introduction / Gerd Hanekamp -- Corporate ethics and globalization : global rules and private actors / Horst Steinmann -- Research priorities, profits, and public goods : the case of drug resistant disease / Michael J. Selgelid -- Ethical issues associated with pharmaceutical innovation / Margaret L. Eaton -- Corporate responsibility for innovation : a citizenship framework / Dirk Matten, Andy Crane and Jeremy Moon -- Access to medicines and the innovation dilemma : can pharmaceutical multinationals be good corporate citizens? / Andreas Seiter -- IT innovations & open source : a question of business ethics or business model? / Marcus Nüttgens.
650 0 $aBusiness ethics.$0http://id.loc.gov/authorities/subjects/sh85018297
650 0 $aTechnological innovations$xMoral and ethical aspects.
650 0 $aPharmaceutical industry$xMoral and ethical aspects.
650 07 $aWirtschaftsethik.$2swd
700 1 $aHanekamp, Gerd.$0http://id.loc.gov/authorities/names/n97103055
830 0 $aWissenschaftsethik und Technikfolgenbeurteilung ;$vBd. 31.$0http://id.loc.gov/authorities/names/n99255063
852 00 $boff,bus$hHF5387$i.B8726 2007g